A detailed history of Ameritas Advisory Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ameritas Advisory Services, LLC holds 8,216 shares of LLY stock, worth $6.54 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
8,216
Previous 14,453 43.15%
Holding current value
$6.54 Million
Previous $13.1 Million 44.38%
% of portfolio
0.32%
Previous 0.51%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$772.14 - $960.02 $4.82 Million - $5.99 Million
-6,237 Reduced 43.15%
8,216 $7.28 Million
Q2 2024

Jul 29, 2024

BUY
$724.87 - $909.04 $857,521 - $1.08 Million
1,183 Added 8.91%
14,453 $13.1 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $1.13 Million - $1.51 Million
1,906 Added 16.77%
13,270 $10.3 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $403,871 - $476,110
-769 Reduced 6.34%
11,364 $6.62 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $2.94 Million - $4.05 Million
6,764 Added 125.98%
12,133 $6.52 Million
Q2 2023

Jul 25, 2023

SELL
$350.74 - $468.98 $909,468 - $1.22 Million
-2,593 Reduced 32.57%
5,369 $2.52 Million
Q1 2023

Apr 28, 2023

SELL
$310.63 - $364.82 $397,917 - $467,334
-1,281 Reduced 13.86%
7,962 $2.73 Million
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $580,076 - $675,904
1,804 Added 24.25%
9,243 $3.38 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $33,502 - $38,179
113 Added 1.54%
7,439 $2.41 Million
Q2 2022

Aug 10, 2022

SELL
$278.73 - $327.27 $64,386 - $75,599
-231 Reduced 3.06%
7,326 $2.38 Million
Q1 2022

May 04, 2022

SELL
$234.69 - $291.66 $79,090 - $98,289
-337 Reduced 4.27%
7,557 $2.16 Million
Q4 2021

Feb 07, 2022

BUY
$224.85 - $279.04 $1.77 Million - $2.2 Million
7,894 New
7,894 $2.18 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ameritas Advisory Services, LLC Portfolio

Follow Ameritas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Advisory Services, LLC with notifications on news.